Literature DB >> 2684300

Immunocytochemical detection of p21ras expression in fresh human leukaemic cells and cell lines.

A Neubauer1, H Herbst, C Rochlitz, W Siegert, C A Schmidt, D Huhn.   

Abstract

The expression of p21ras proteins was investigated by immunocytochemistry in permanent cell lines and in fresh human leukaemic cells. While high and low levels of p21ras could be detected in most of the cell lines, no significant p21ras immunoreactivity was noted in cells of ten human acute and chronic leukaemias. Thus, notwithstanding its possible role in the initial transformation process in human leukaemias, p21ras expression appears not to be an irrevocable requirement for the maintenance of the transformed state.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684300     DOI: 10.1007/bf00349069

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

1.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Increased expression of oncogene c-Ha-ras during granulocytic differentiation of HL60 cells.

Authors:  G P Studzinski; Z S Brelvi
Journal:  Lab Invest       Date:  1987-05       Impact factor: 5.662

Review 3.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Expression of normal and mutant ras proteins in human acute leukemia.

Authors:  W P Shen; T H Aldrich; G Venta-Perez; B R Franza; M E Furth
Journal:  Oncogene       Date:  1987-05       Impact factor: 9.867

6.  Mutations in N-ras predominate in acute myeloid leukemia.

Authors:  J L Bos; M Verlaan-de Vries; A J van der Eb; J W Janssen; R Delwel; B Löwenberg; L P Colly
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

7.  Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.

Authors:  P G Chesa; W J Rettig; M R Melamed; L J Old; H L Niman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Cellular ras oncogene expression and cell cycle measured by flow cytometry in hematopoietic cell lines.

Authors:  M Andreeff; D E Slater; J Bressler; M E Furth
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

9.  Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.

Authors:  J Lyons; J W Janssen; C Bartram; M Layton; G J Mufti
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

10.  A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.

Authors:  H Hirai; Y Kobayashi; H Mano; K Hagiwara; Y Maru; M Omine; H Mizoguchi; J Nishida; F Takaku
Journal:  Nature       Date:  1987 Jun 4-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.